Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Mild to Moderate Ankle Sprain
The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Mild to Moderate Ankle Sprain
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hisamitsu Investigator Site
Birmingham, Alabama, United States
Hisamitsu Investigator Site
Phoenix, Arizona, United States
Hisamitsu Investigator Site
Tucson, Arizona, United States
Hisamitsu Investigator Site
Hot Springs, Arkansas, United States
Hisamitsu Investigator Site
Anaheim, California, United States
Hisamitsu Investigator Site
Anaheim, California, United States
Hisamitsu Investigator Site
Buena Park, California, United States
Hisamitsu Investigator Site
Long Beach, California, United States
Hisamitsu Investigator Site
San Diego, California, United States
Hisamitsu Investigator Site
San Luis Obispo, California, United States
Start Date
July 1, 2009
Primary Completion Date
November 1, 2010
Completion Date
November 1, 2010
Last Updated
June 4, 2015
240
ACTUAL participants
Ketoprofen Patch
DRUG
Placebo Patch
OTHER
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
NCT06868316
NCT06897293
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03643926